Terumo Corp ADR TRUMY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TRUMY is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $17.51
- Day Range
- $17.10–18.10
- 52-Week Range
- $12.56–20.60
- Bid/Ask
- $17.38 / $18.04
- Market Cap
- $26.31 Bil
- Volume/Avg
- 31,493 / 43,656
Key Statistics
- Price/Earnings (Normalized)
- 30.35
- Price/Sales
- 4.13
- Dividend Yield (Trailing)
- 0.81%
- Dividend Yield (Forward)
- 0.81%
- Total Yield
- 1.10%
Company Profile
Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management, cardiac and vascular, and general hospital. The cardiac and vascular business generates the largest proportion of revenue and sells cardiac and endovascular interventional therapies, cardiovascular surgical systems, neurovascular products, and vascular graft products. The general hospital business includes diabetes management, consumer healthcare, drug and device technologies, and general hospital products. The blood management business sells blood component, therapeutic apheresis, and cellular technologies. Terumo generates the majority of its revenue in Asia, with Japan contributing the largest proportion of Asian revenue.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Large Growth
- Total Number of Employees
- 30,591
- Website
- https://www.terumo.com
Comparables
Valuation
|
Metric
|
TRUMY
|
7575
|
NUVA
|
|---|---|---|---|
Price/Earnings (Normalized) | 30.35 | 11.14 | 19.87 |
Price/Book Value | 3.00 | 1.48 | 2.34 |
Price/Sales | 4.13 | 1.73 | 1.79 |
Price/Cash Flow | 21.63 | 9.25 | 11.86 |
Price/Earnings
TRUMY
7575
NUVA
Financial Strength
|
Metric
|
TRUMY
|
7575
|
NUVA
|
|---|---|---|---|
Quick Ratio | 1.08 | 1.83 | 0.60 |
Current Ratio | 1.90 | 3.02 | 1.25 |
Interest Coverage | 50.48 | 401.73 | 2.90 |
Quick Ratio
TRUMY
7575
NUVA
Profitability
|
Metric
|
TRUMY
|
7575
|
NUVA
|
|---|---|---|---|
Return on Assets (Normalized) | 6.36% | 14.73% | 4.87% |
Return on Equity (Normalized) | 8.88% | 18.78% | 12.28% |
Return on Invested Capital (Normalized) | 7.44% | 17.01% | 6.21% |
Return on Assets
TRUMY
7575
NUVA
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| Vrwsqmdjy | Nbz | $156.8 Bil | |||
| Becton Dickinson & Co
BDX
| Kksztttk | Wqgrzsv | $68.6 Bil | |||
| Alcon Inc
ALC
| Hckpmggr | Jgfpqg | $46.5 Bil | |||
| Coloplast A/S ADR
CLPBY
| Mnbqrpqfc | Ktbm | $29.2 Bil | |||
| ResMed Inc
RMD
| Kcxxxcfdgk | Jfynty | $28.9 Bil | |||
| West Pharmaceutical Services Inc
WST
| Jbfkjzvwh | Pxm | $20.2 Bil | |||
| The Cooper Companies Inc
COO
| Jlmyrzvc | Yslsdy | $18.5 Bil | |||
| Hologic Inc
HOLX
| Tzpgrnf | Njtshw | $18.2 Bil | |||
| Baxter International Inc
BAX
| Zqykfqsq | Qtykc | $18.1 Bil | |||
| Teleflex Inc
TFX
| Fvfbf | Fznh | $10.4 Bil |